CRISPR And CRISPR-Associated (Cas) Genes Market 2018 Global Trend, Segmentation And Opportunities Forecast To 2023

CRISPR And CRISPR-Associated (Cas) Genes
CRISPR And CRISPR-Associated (Cas) Genes -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023

CRISPR And CRISPR-Associated (Cas) Genes Industry

Description

Wiseguyreports.Com Adds “CRISPR And CRISPR-Associated (Cas) Genes -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

This report studies the global CRISPR And CRISPR-Associated (Cas) Genes market status and forecast, categorizes the global CRISPR And CRISPR-Associated (Cas) Genes market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of “spacer DNA” from previous exposures to a bacteriophage virus or plasmid. 
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.

CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45.70% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes. 
Although this market has great potential for future development, we do not recommend entering the market for investors who do not have strong capital or do not have key technology. 

The global CRISPR And CRISPR-Associated (Cas) Genes market is valued at 350 million US$ in 2017 and will reach 5220 million US$ by the end of 2025, growing at a CAGR of 40.0% during 2018-2025.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3269153-global-crispr-and-crispr-associated-cas-genes-market-research-report-2018

The major manufacturers covered in this report 

Caribou Biosciences 
Addgene 
CRISPR THERAPEUTICS 
Merck KGaA 
Mirus Bio LLC 
Editas Medicine 
Takara Bio USA 
Thermo Fisher Scientific 
Horizon Discovery Group 
Intellia Therapeutics 
GE Healthcare Dharmacon

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering 
North America 
Europe 
China 
Japan 
Southeast Asia 
India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into 
Genome Editing 
Genetic engineering 
gRNA Database/Gene Librar 
CRISPR Plasmid 
Human Stem Cells 
Genetically Modified Organisms/Crops 
Cell Line Engineering 

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including 
Biotechnology Companies 
Pharmaceutical Companies 
Academic Institutes 
Research and Development Institutes

Leave a Query @ https://www.wiseguyreports.com/enquiry/3269153-global-crispr-and-crispr-associated-cas-genes-market-research-report-2018

 

Table of Contents

Global CRISPR And CRISPR-Associated (Cas) Genes Market Research Report 2018 
1 CRISPR And CRISPR-Associated (Cas) Genes Market Overview 
1.1 Product Overview and Scope of CRISPR And CRISPR-Associated (Cas) Genes 
1.2 CRISPR And CRISPR-Associated (Cas) Genes Segment by Type (Product Category) 
1.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Production and CAGR (%) Comparison by Type (Product Category)(2013-2025) 
1.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Production Market Share by Type (Product Category) in 2017 
1.2.3 Genome Editing 
1.2.4 Genetic engineering 
1.2.5 gRNA Database/Gene Librar 
1.2.6 CRISPR Plasmid 
1.2.7 Human Stem Cells 
1.2.8 Genetically Modified Organisms/Crops 
1.2.9 Cell Line Engineering 
1.3 Global CRISPR And CRISPR-Associated (Cas) Genes Segment by Application 
1.3.1 CRISPR And CRISPR-Associated (Cas) Genes Consumption (Sales) Comparison by Application (2013-2025) 
1.3.2 Biotechnology Companies 
1.3.3 Pharmaceutical Companies 
1.3.4 Academic Institutes 
1.3.5 Research and Development Institutes 
1.4 Global CRISPR And CRISPR-Associated (Cas) Genes Market by Region (2013-2025) 
1.4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size (Value) and CAGR (%) Comparison by Region (2013-2025) 
1.4.2 North America Status and Prospect (2013-2025) 
1.4.3 Europe Status and Prospect (2013-2025) 
1.4.4 China Status and Prospect (2013-2025) 
1.4.5 Japan Status and Prospect (2013-2025) 
1.4.6 Southeast Asia Status and Prospect (2013-2025) 
1.4.7 India Status and Prospect (2013-2025) 
1.5 Global Market Size (Value) of CRISPR And CRISPR-Associated (Cas) Genes (2013-2025) 
1.5.1 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Status and Outlook (2013-2025) 
1.5.2 Global CRISPR And CRISPR-Associated (Cas) Genes Capacity, Production Status and Outlook (2013-2025)

7 Global CRISPR And CRISPR-Associated (Cas) Genes Manufacturers Profiles/Analysis 
7.1 Caribou Biosciences 
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.1.2 CRISPR And CRISPR-Associated (Cas) Genes Product Category, Application and Specification 
7.1.2.1 Product A 
7.1.2.2 Product B 
7.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.1.4 Main Business/Business Overview 
7.2 Addgene 
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Category, Application and Specification 
7.2.2.1 Product A 
7.2.2.2 Product B 
7.2.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.2.4 Main Business/Business Overview 
7.3 CRISPR THERAPEUTICS 
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.3.2 CRISPR And CRISPR-Associated (Cas) Genes Product Category, Application and Specification 
7.3.2.1 Product A 
7.3.2.2 Product B 
7.3.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.3.4 Main Business/Business Overview 
7.4 Merck KGaA 
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.4.2 CRISPR And CRISPR-Associated (Cas) Genes Product Category, Application and Specification 
7.4.2.1 Product A 
7.4.2.2 Product B 
7.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.4.4 Main Business/Business Overview 
7.5 Mirus Bio LLC 
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.5.2 CRISPR And CRISPR-Associated (Cas) Genes Product Category, Application and Specification 
7.5.2.1 Product A 
7.5.2.2 Product B 
7.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Capacity, Production, Revenue, Price and Gross Margin (2015-2018) 
7.5.4 Main Business/Business Overview 
7.6 Editas Medicine 
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.6.2 CRISPR And CRISPR-Associated (Cas) Genes Product Category, Application and Specification 
7.6.2.1 Product A 
7.6.2.2 Product B 
7.6.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.6.4 Main Business/Business Overview 
7.7 Takara Bio USA 
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.7.2 CRISPR And CRISPR-Associated (Cas) Genes Product Category, Application and Specification 
7.7.2.1 Product A 
7.7.2.2 Product B 
7.7.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.7.4 Main Business/Business Overview 
7.8 Thermo Fisher Scientific 
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.8.2 CRISPR And CRISPR-Associated (Cas) Genes Product Category, Application and Specification 
7.8.2.1 Product A 
7.8.2.2 Product B 
7.8.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.8.4 Main Business/Business Overview 
7.9 Horizon Discovery Group 
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.9.2 CRISPR And CRISPR-Associated (Cas) Genes Product Category, Application and Specification 
7.9.2.1 Product A 
7.9.2.2 Product B 
7.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Capacity, Production, Revenue, Price and Gross Margin (2013-2018) 
7.9.4 Main Business/Business Overview 
7.10 Intellia Therapeutics 
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 
7.10.2 CRISPR And CRISPR-Associated (Cas) Genes Product Category, Application and Specification 
7.10.2.1 Product A 
7.10.2.2 Product B 
7.10.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Capacity, Production, Revenue, Price and Gross Margin (2013-2020) 
7.10.4 Main Business/Business Overview 
7.11 GE Healthcare Dharmacon

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3269153

Continued…                       

 

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

 

Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: https://www.wiseguyreports.com/sample-request/3269153-global-crispr-and-crispr-associated-cas-genes-market-research-report-2018